Considering that GW displayed notably encouraging performance in suppressing tumour metastatic potential when MLKL was overexpressed (Fig. 9d, e, Fig. 3g, j), we further scrutinized its off-target effects since it has also been reported to inhibit VEGFR2, a pivotal angiogenic factor47,52,53. The gene discussed is MLKL; the disease is neoplasm.